文献速递高血压血脂与心血管预防心力衰竭与心肌病

心血管合并症患者的高血压管理

Hypertension management in patients with cardiovascular comorbidities.
PubMed 文献 · Eur Heart J · 2023-01-01

动脉性高血压是全球主要死因,常与2型糖尿病、肥胖、血脂异常、久坐和吸烟共存并放大风险。降压治疗可降低心血管病残率和死亡率,指南推荐联合方案;新药与肾去神经术为合并症患者提供新选择。

要点

  • 降压治疗可降低心血管病残率和死亡率。
  • 指南推荐联合使用RAS阻滞剂、CCB和/或利尿剂。
  • 新药与肾去神经术可改善合并症患者结局。

核心结论

  • 生活方式调整与降压药物降低心血管病残率和死亡率。
  • 合并症常使高血压管理复杂化,需个体化选择药物。

研究设计与样本

  • 综述,总结合并心血管合并症的高血压管理最新临床证据。

主要发现

  • 高血压常与2型糖尿病、肥胖、血脂异常、久坐和吸烟共存并放大风险。
  • ARNI、SGLT2抑制剂、GLP-1RA和非甾体MRA改善心血管和肾脏结局。
  • 导管肾去神经术或可用于交感神经活性增高的合并症高血压。

关键数值与推荐

  • 指南推荐使用RAS阻滞剂、钙通道阻滞剂和/或利尿剂的双联或三联治疗。

临床怎么用

  • 根据合并症选择降压药物组合,优先循证联合方案。
  • 对合并症患者可考虑新药或肾去神经术以改善结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Arterial hypertension is a leading cause of death globally. Due to ageing, the rising incidence of obesity, and socioeconomic and environmental changes, its incidence increases worldwide. Hypertension commonly coexists with Type 2 diabetes, obesity, dyslipidaemia, sedentary lifestyle, and smoking leading to risk amplification. Blood pressure lowering by lifestyle modifications and antihypertensive drugs reduce cardiovascular (CV) morbidity and mortality. Guidelines recommend dual- and triple-combination therapies using renin-angiotensin system blockers, calcium channel blockers, and/or a diuretic. Comorbidities often complicate management. New drugs such as angiotensin receptor-neprilysin inhibitors, sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor agonists, and non-steroidal mineralocorticoid receptor antagonists improve CV and renal outcomes. Catheter-based renal denervation could offer an alternative treatment option in comorbid hypertension associated with increased sympathetic nerve activity. This review summarises the latest clinical evidence for managing hypertension with CV comorbidities.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Lauder L, Mahfoud F, Azizi M, et al. Hypertension management in patients with cardiovascular comorbidities. Eur Heart J. 2023. PMID: 36342266. doi:10.1093/eurheartj/ehac395

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。